글로벌 줄기세포 은행 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

줄기세포 은행 시장 분석

시장은 지난 몇 년 동안 치명적인 만성 질환을 앓는 사람들의 수가 급증함에 따라 예측 기간 동안 확대될 것으로 예상됩니다   . 질병 통제 예방 센터(CDC)에 따르면 2020년에 약 3,613,647명의 아기가 보고될 예정입니다. 만성 질환의 급증은 만성 질환 관리에 대한 지출을 증가시켜 시장에 도움이 될 것입니다. 결과적으로 시장은 다양한 성장 요인으로 추진되고 있으며 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다.

줄기세포 은행 시장 규모

글로벌 줄기세포 은행 시장 규모는 2023년에 67억 3천만 달러로 평가되었으며, 2031년까지 222억 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 연평균 성장률은 16.1%입니다.

보고 범위 및 시장 세분화       

Stem Cell Banking Market Definition

Stem cells are cells that can self-renew and differentiate into a variety of cell lineages. These can be found in all stages of life in humans, from infancy to death. The stem cell banking technique involves storing stem cells from a variety of sources and is widely used in research and clinical settings.

Stem Cell Banking Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

• Surging Requirement for Stem Cell Banking

The increase in the global burden of major diseases and rise in the use of stem cell banking for curing badly damaged tissues are the most significant factors driving this market's growth. The surge in hematopoietic stem cell transplantation procedures and the increase in the number of skin transplants and brain cell transplantations are also expected to accelerate the market's overall growth.

• Surging Awareness

The various initiatives for instilling awareness amongst consumers by government as well as non-government organizations about the therapeutic potentials of stem cells will bolster the overall growth of the market.

Furthermore, the rise in population and expansion of biotechnology sector are also expected to fuel market growth. Moreover, the rise in gross domestic product (GDP) of respective underdeveloped and developing economies also cushions the market’s growth within the forecasted period. The increasing approval of clinical trials in stem cell research is also projected to bolster the market's growth.

Opportunities

• Growing Investments and Advancements

Moreover, the development of novel technologies for stem cell preservation, processing and storage are estimated to generate lucrative opportunities for the market. The increasing investments in stem cell-based research will further offer numerous growth opportunities for the market.

Restraints/Challenges 

• High Costs

On the other hand, the high operational costs of stem cell transplantation is expected to obstruct market growth. Also, the stringent regulatory frameworks and socio-ethical concerns related to embryonic stem cells are projected to challenge the stem cell banking market in the forecast period of 2024-2031.

This stem cell banking market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the stem cell banking market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Stem Cell Banking Market

The outbreak of COVID-19 is expected to have a negative impact on the stem cell banking industry's growth. COVID-19 further resulted in a severe public health concern. The government's imposition of the lockdown and social distancing restrictions to curb the COVID-19 pandemic outbreak led to halt of various stem cell harvest processes, supply chain disruptions, stifling business growth, technology event cancellations suspensions of new developments and has affected the overall production and sales.

On the brighter side, the clinical trials for the use of stem cells in the treatment of COVID-19, could help the industry flourish after the pandemic. With gradual increment in clinical trials for usage of stem cells treatment, the market will witness a lucrative growth.

Stem Cell Banking Market Scope

The stem cell banking market is segmented on the basis of source, product, bank type, service type, utilization and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Source

• Placental Stem Cells (PSCs)
• Human Embryo-Derived Stem Cells (hESCs)
• Bone Marrow-Derived Stem Cells (BMSCs)
• Dental Pulp-Derived Stem Cells (DPSCS)
• Adipose Tissue-Derived Stem Cells (ADSCs)
• Other Stem Cell Sources

Product

• Adult Stem Cells
• Human Embryonic Cells
• IPS Cells

Bank Type

• Private
• Public

Service Type

• Sample Collection and Transportation
• Sample Processing, Sample Analysis
• Sample Preservation, Storage

Utilization

• Used
• Unused

Application

• Personalized Storage
• Clinical
• Research

Stem Cell Banking Market Regional Analysis

The stem cell banking market is analyzed and market size insights and trends are provided by country, source, product, bank type, service type, utilization and application as referenced above.

The countries covered in the stem cell banking market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the stem cell banking market because of the prevalence of chronic diseases and expanding network of stem cell banking services within the region.

Asia-Pacific is expected to witness significant growth during the forecast period of 2024 to 2031 due to the increase in patient population along with the developing healthcare infrastructure within the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The stem cell banking market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for stem cell banking market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the stem cell banking market. The data is available for historic period 2010-2020.

Stem Cell Banking Market Share

The stem cell banking market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to stem cell banking market.

Stem Cell Banking Market Leaders Operating in the Market Are:

• CBR Systems, Inc., (U.S.)
• Cordlife (Singapore)
• Cryo-Cell International, Inc., (U.S.)
• ViaCord (U.S.)
• Cryo-Save (Netherlands)
• LifeCell International Pvt. Ltd.  (India)
• StemCyte India Therapeutics Pvt. Ltd (U.S.)
• 글로벌코드블러드(중국)
• 스마트셀스 인터내셔널 리미티드(영국)
• Vita34 1997 (독일)
• 칼라드리우스 바이오사이언스(Caladrius Biosciences, Inc.) (미국)
• 셀진 코퍼레이션(미국)
• 브레인스톰 셀 리미티드(미국)
• Regrow Biosciences Pvt. Ltd. (인도)
• CryoHoldco(멕시코)
• Cryo-Save(네덜란드)

줄기세포 은행 시장의 최신 동향

• 2021년 2월, BioTherapeutic Labs Corp와 생명공학 기업인 American CryoStem이 줄기세포 연구 개발을 위한 협업 계약을 체결했습니다. BTL은 CRYO의 상품과 서비스를 판매하고, 두 회사는 CRYO의 ATCell® 자가 중간엽 줄기세포와 BTL의 인간 탯줄 기반 제품 라인을 사용하는 프로토콜을 만들고 개선하기 위한 R&D 노력에 협력할 것입니다. 두 회사는 ATCellTM 제조, 제품 개발 및 엔드투엔드 CryoStem 플랫폼 기술과 함께 사용할 수 있도록 탯줄 무세포 현탁 제품을 검증하고 표준화할 계획입니다.

SKU-14327